Lexaria Bioscience Corp. (LEXX)
Market Open
11 Aug, 17:38
NASDAQ (CM) NASDAQ (CM) Primary $
5. 63
+0.14
+2.5319%
$
8.71M Market Cap
- P/E Ratio
- Div Yield
5,276 Volume
0 Eps
$ 5.49
Previous Close Investors:
Want to track LEXX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexaria Bioscience Corp. (LEXX) Statistics
Valuation metrics
Market Cap 8.71M
Enterprise value 5.32M
Trailing P/E (ttm) -0.99
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 44.89
Price/Book (mrq) 1.84
Enterprise Value/Revenue 27.42
Enterprise Value/EBITDA -0.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 24.93K
Average volume (90 days) 86.5K
Price summary
52-Week low 4.21
52-Week high 23.25
Beta -
50-Day moving average 3.71
200-Day moving average 1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 3 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -39.86%
Operating margin -39.73%
Operational effectiveness
Return on assets -1.62%
Return on equity -1.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.6%
Book value per share (mrq) 2.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
